Litigation Details for Meijer Distribution, Inc. v. Allergan, Inc. (D. Mass. 2016)
✉ Email this page to a colleague
Meijer Distribution, Inc. v. Allergan, Inc. (D. Mass. 2016)
| Docket | ⤷ Try a Trial | Date Filed | 2016-08-26 |
| Court | District Court, D. Massachusetts | Date Terminated | 2019-09-05 |
| Cause | 15:2 Antitrust Litigation | Assigned To | Denise Jefferson Casper |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 6,649,180; 6,893,662; 8,580,302 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Meijer Distribution, Inc. v. Allergan, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Details for Meijer Distribution, Inc. v. Allergan, Inc. (D. Mass. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2016-04-26 | 1 | on Delzicol is covered by U.S. Patent No. 6,649,180 (“the ’180 patent”), which expires April 13, 2020…the ’170 patent”) and 5,541,171 (“the ’171 patent”). Both patents expired July 30, 2013. 80. …would push Asacol (400mg) over the “patent cliff” – upon patent expiry in July 2013, Warner Chilcott …alleged infringement of that patent. Warner Chilcott’s listing of the capsule patent in the Orange Book, and…assertion that the patent claimed the drug product, was grossly improper: the patent claims only the capsules | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
